These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35681579)

  • 21. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
    Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
    Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
    Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
    Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
    Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surviving hypopharynx-larynx carcinoma in the era of IMRT.
    Studer G; Peponi E; Kloeck S; Dossenbach T; Huber G; Glanzmann C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1391-6. PubMed ID: 20056352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.
    Dolezel M; Odrazka K; Vaculikova M; Vanasek J; Sefrova J; Paluska P; Zouhar M; Jansa J; Macingova Z; Jarosova L; Brodak M; Moravek P; Hartmann I
    Strahlenther Onkol; 2010 Apr; 186(4):197-202. PubMed ID: 20354663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
    Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
    Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03.
    Choi KH; Ahn SJ; Jeong JU; Yu M; Kim JH; Jeong BK; Lee JH; Kim SH; Lee JH
    Radiother Oncol; 2021 Jan; 154():179-186. PubMed ID: 32980384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
    [No Abstract]   [Full Text] [Related]  

  • 31. Post-operative radiation therapy for non-small cell lung cancer: A comparison of radiation therapy techniques.
    Jairam V; Pasha S; Soulos PR; Gross CP; Yu JB; Park HS; Decker RH
    Lung Cancer; 2021 Nov; 161():171-179. PubMed ID: 34607209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
    Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
    J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.
    Thibouw D; Truc G; Bertaut A; Chevalier C; Aubignac L; Mirjolet C
    J Neurooncol; 2018 Apr; 137(2):429-438. PubMed ID: 29374810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy.
    Shimoyachi N; Yoshioka Y; Sasamura K; Yonese J; Yamamoto S; Yuasa T; Soyano T; Kozuka T; Oguchi M
    Adv Radiat Oncol; 2021; 6(6):100753. PubMed ID: 34934854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer.
    Lan ML; Yu X; Xiao H; Zhou P; Hu N; Li J; Wang G
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):430-436. PubMed ID: 26923341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme.
    Chen YD; Feng J; Fang T; Yang M; Qiu XG; Jiang T
    Chin Med J (Engl); 2013 Jun; 126(12):2320-4. PubMed ID: 23786946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer: minimization of late dysphagia without jeopardizing tumor control.
    Modesto A; Laprie A; Vieillevigne L; Graff P; Sarini J; Vergez S; Delord JP; Farenc JC; Vigarios E; Filleron T; Rives M
    Strahlenther Onkol; 2015 Mar; 191(3):225-33. PubMed ID: 25367098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis.
    Yang B; Zhu L; Cheng H; Li Q; Zhang Y; Zhao Y
    Radiat Oncol; 2012 Nov; 7():197. PubMed ID: 23176540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
    Dewas CV; Maingon P; Dalban C; Petitfils A; Peignaux K; Truc G; Martin E; Khoury C; Dewas S; Créhange G
    Radiat Oncol; 2012 Nov; 7():201. PubMed ID: 23190693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.